Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab): clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Anti-CD20 Therapy | 1 |
| Multiple sclerosis | 1 |
| Relapsing-Remitting Multiple Sclerosis (RRMS) | 1 |
Recruiting trials involving Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab)
Common questions
How many recruiting trials involve Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab)?
1 recruiting trial across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.